{"meta":{"humanUrl":"https://us-uk.bookimed.com/clinics/country=republic-of-korea/procedure=car-t-cell-therapy/best/","canonicalUrl":"https://us-uk.bookimed.com/clinics/country=republic-of-korea/procedure=car-t-cell-therapy/best/","jsonUrl":"https://us-uk.bookimed.com/clinics/country=republic-of-korea/procedure=car-t-cell-therapy/best/data.json","title":"Best clinics for CAR T-cell therapy in Republic of Korea — Ratings & Reviews | Bookimed","description":"1 top-rated clinics for CAR T-cell therapy in Republic of Korea. Compare rankings, prices, and patient reviews on Bookimed.","heading":"Best clinics for CAR T-cell therapy in Republic of Korea","locale":"en","schemaVersion":"ClinicBestPageDataV1","snapshotId":"09868d4c-b0ee109c","contentVersion":"09868d4c","generatedAt":"2026-11-22T20:19:54.150Z"},"filters":{"country":"republic-of-korea","procedure":"car-t-cell-therapy","page":1},"pagination":{"page":1,"totalCount":1,"totalPages":1},"breadcrumbs":[{"name":"Home","url":"/"},{"name":"Clinics","url":"/clinics/"},{"name":"Republic of Korea","url":"/clinics/country=republic-of-korea/"},{"name":"CAR T-cell therapy","url":"/clinics/country=republic-of-korea/procedure=car-t-cell-therapy/"},{"name":"Best","url":"/clinics/country=republic-of-korea/procedure=car-t-cell-therapy/best/"}],"entities":[{"name":"Republic of Korea","alias":"republic-of-korea","type":"country","id":36},{"name":"CAR T-cell therapy","alias":"car-t-cell-therapy","type":"procedure","id":800}],"clinics":{"clinics":[{"text":"<p>Samsung Medical Center's Comprehensive Cancer Center provides CAR T-cell therapy using state-of-the-art equipment, including the Da Vinci surgical system. The center holds a special status as a \"Hospital of presidential standards\" and has received numerous awards for service quality. Dr. Keun Chil Park, a hematologist-oncologist with membership in ASCO, AACR, and ESMO, specializes in treating hematologic cancers.</p><doctor id=\"1086\"></doctor>","text_type":"mt_wow_description","best_texts":{"why_its_ranked":"Asia's largest cancer center with 78 oncology beds, 50,000+ patients treated, and 17 cancer-specific departments. On-site Research Institute runs clinical trials for emerging CAR T therapies."},"agency_settings":[{"setting_name":"is_new","setting_value":"0"},{"setting_name":"kids_only","setting_value":"0"}],"procedure_prices":[{"prices":{"price_from":600,"price_to":950,"currency":"USD","id":14151},"diagnostic":{"id":6,"name":"MRI of one area","alias":"mri-one-department"}},{"prices":{"price_from":150,"price_to":300,"currency":"USD","id":14150},"diagnostic":{"id":37,"name":"Ultrasound","alias":"u.s."}}],"reviews":[],"clinic":{"id":262,"alias":"samsung-medical-center","name":"Samsung Medical Center","short_description":"<p>Samsung Medical Center is a multidisciplinary hospital in Seoul with “hospital of presidential standards” status. Its top specialties are oncology, cardiology, vascular care, stroke, and organ transplantation. The hospital holds a partnership with the Mayo Clinic and earned Newsweek’s World’s Best Hospitals recognition.</p> <ul> <li>Houses Asia’s largest cancer center with 17 disease-specific departments and proton beam therapy.</li> <li>Ranks #1 in Korea’s Customer Satisfaction and Quality Indexes, named Top Medical Center 12 times in a row.</li> <li>Performs over 45,000 surgeries and treats 2 million outpatients each year.</li> <li>Uses an integrated digital system with real-time X-ray, CT, and MRI image sharing for faster care.</li> </ul>","images":[{"base_url":"clinic/5c87c575c04f2","title":"Samsung Medical Center modern clinic building in Seoul, South Korea"},{"base_url":"clinic/5b51a282dd084","title":"Samsung Medical Center exterior view in Seoul, modern hospital buildings"},{"base_url":"clinic/5b51a28378e14","title":"Reception area at Samsung Medical Center International Health Services, Seoul"},{"base_url":"clinic/5b51a2805bea6","title":"Patient lounge at Samsung Medical Center, Seoul with comfortable seating and dining area"}],"flags":[{"name":"is_hide","value":false},{"name":"has_active_agencies","value":true}],"geo":{"country":{"name":"Republic of Korea","id":36,"alias":"republic-of-korea","iso_code":"KR"},"city":{"name":"Seoul","id":328,"alias":"seoul"},"address":"81 Irwon-ro, Irwon-dong, Gangnam-gu, Seoul, South Korea"},"rating":{"rating":4.5,"google":3.9,"percent_of_satisfied_clients":88},"statistics":{"number_of_reviews":25,"doctors_number":1400,"year_foundation":1994},"accreditations":[{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5db982e01da4b.jpeg","name":"International Organization for Standardization","country_code":"CH"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5df76f5a0c887.jpeg","name":"Korean Institute for Healthcare Accreditation","country_code":"KR"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/609cdeda74941.jpeg","name":"World's Best Hospitals 2021 by Newsweek","country_code":"US"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/60d499a36ac19.jpeg","name":"World's Best Smart Hospitals 2021 by Newsweek","country_code":"US"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/636103a731801.jpeg","name":"World's Best Hospitals 2022 by Newsweek","country_code":"US"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/6360fa074cde8.jpeg","name":"World's Best Smart Hospitals 2023 by Newsweek","country_code":"US"}],"agency_settings":[{"setting_name":"is_new","setting_value":"0"},{"setting_name":"kids_only","setting_value":"0"}]}}],"meta":{"total_count":1,"total_pages":1}},"clinicsMeta":{"total_count":1,"total_pages":1},"clinicsCount":1,"clinicsCountByEntity":{"clinic_count":30},"doctors":{"doctors":[{"doctor":{"id":1086,"alias":"keun-chil-park","name":"Keun Chil Park","clinic_id":262,"photo":"doctor/5acf6105e7053","first_year_working":0,"created_at":"2017-09-12T13:18:29.000+00:00","short_description":"<p>Dr. Keun Chil Park leads the Division of Hematology-Oncology at Samsung Medical Center in Seoul. He specializes in treating lung, esophageal, and head and neck cancers. Dr. Park earned his medical degree from Seoul National University College of Medicine.</p> <ul> <li>Member of the American Society of Clinical Oncology (ASCO).</li> <li>Member of the European Society of Medical Oncology (ESMO).</li> <li>Affiliated with the International Association for the Study of Lung Cancer.</li> <li>Works at a hospital ranked among the world’s best by Newsweek.</li> </ul>","statistics":{"review_count":0,"review_score":0,"operations_performed_count":0,"awards_count":0},"certificates":[{"url":"https://s3.eu-central-1.amazonaws.com/bookimed/doctor/certificate/659c760fc58ec.jpeg","name":"Korean Medical Association"},{"url":"https://s3.eu-central-1.amazonaws.com/bookimed/doctor/certificate/659c76121a411.jpeg","name":"American Society of Clinical Oncology"},{"url":"https://s3.eu-central-1.amazonaws.com/bookimed/doctor/certificate/659c76144234a.jpeg","name":"American Association for Cancer Research"},{"url":"https://s3.eu-central-1.amazonaws.com/bookimed/doctor/certificate/659c761904f68.jpeg","name":"International Association for the Study of Lung Cancer"}]},"clinic":{"id":262,"alias":"samsung-medical-center","name":"Samsung Medical Center","short_description":"<p>Samsung Medical Center is a multidisciplinary hospital in Seoul with “hospital of presidential standards” status. Its top specialties are oncology, cardiology, vascular care, stroke, and organ transplantation. The hospital holds a partnership with the Mayo Clinic and earned Newsweek’s World’s Best Hospitals recognition.</p> <ul> <li>Houses Asia’s largest cancer center with 17 disease-specific departments and proton beam therapy.</li> <li>Ranks #1 in Korea’s Customer Satisfaction and Quality Indexes, named Top Medical Center 12 times in a row.</li> <li>Performs over 45,000 surgeries and treats 2 million outpatients each year.</li> <li>Uses an integrated digital system with real-time X-ray, CT, and MRI image sharing for faster care.</li> </ul>","images":[{"base_url":"clinic/5c87c575c04f2","title":"Samsung Medical Center modern clinic building in Seoul, South Korea"},{"base_url":"clinic/5b51a282dd084","title":"Samsung Medical Center exterior view in Seoul, modern hospital buildings"},{"base_url":"clinic/5b51a28378e14","title":"Reception area at Samsung Medical Center International Health Services, Seoul"},{"base_url":"clinic/5b51a2805bea6","title":"Patient lounge at Samsung Medical Center, Seoul with comfortable seating and dining area"}],"flags":[{"name":"is_hide","value":false},{"name":"has_active_agencies","value":true}],"geo":{"country":{"name":"Republic of Korea","id":36,"alias":"republic-of-korea","iso_code":"KR"},"city":{"name":"Seoul","id":328,"alias":"seoul"},"address":"81 Irwon-ro, Irwon-dong, Gangnam-gu, Seoul, South Korea"},"rating":{"rating":4.5,"google":3.9,"percent_of_satisfied_clients":88},"statistics":{"number_of_reviews":25,"doctors_number":1400,"year_foundation":1994},"accreditations":[{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5db982e01da4b.jpeg","name":"International Organization for Standardization","country_code":"CH"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/5df76f5a0c887.jpeg","name":"Korean Institute for Healthcare Accreditation","country_code":"KR"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/609cdeda74941.jpeg","name":"World's Best Hospitals 2021 by Newsweek","country_code":"US"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/60d499a36ac19.jpeg","name":"World's Best Smart Hospitals 2021 by Newsweek","country_code":"US"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/636103a731801.jpeg","name":"World's Best Hospitals 2022 by Newsweek","country_code":"US"},{"logo":"https://s3.eu-central-1.amazonaws.com/bookimed/accreditations/6360fa074cde8.jpeg","name":"World's Best Smart Hospitals 2023 by Newsweek","country_code":"US"}]}}],"meta":{"total_count":1,"total_pages":1}},"offers":{"cards":[],"metadata":{"total_count":0}},"listingTexts":{"entity_texts":{},"texts":{}},"relations":{"countries":[{"name":"Austria","alias":"austria","iso_code":"AT"},{"name":"China","alias":"china","iso_code":"CN"},{"name":"Germany","alias":"germany","iso_code":"DE"},{"name":"Israel","alias":"israel","iso_code":"IL"},{"name":"Italy","alias":"italy","iso_code":"IT"},{"name":"Lithuania","alias":"lithuania","iso_code":"LT"},{"name":"Republic of Korea","alias":"republic-of-korea","iso_code":"KR"},{"name":"Spain","alias":"spain","iso_code":"ES"},{"name":"Thailand","alias":"thailand","iso_code":"TH"},{"name":"Turkey","alias":"turkey","iso_code":"TR"},{"name":"United Kingdom","alias":"united-kingdom","iso_code":"GB"},{"name":"United States of America","alias":"united-states","iso_code":"US"}],"cities":[{"name":"Seoul","alias":"seoul"}],"operations":[{"name":"Chemotherapy","alias":"chemotherapy"},{"name":"Bone marrow transplantation","alias":"bone-marrow-transplantation"},{"name":"Allogenic bone marrow transplantation from a related donor","alias":"allogenic-bone-marrow-transplantation-from-a-related-donor"},{"name":"CAR T-cell therapy","alias":"car-t-cell-therapy"},{"name":"Lymphoma chemotherapy","alias":"lymphoma-chemotherapy"},{"name":"Leukemia chemotherapy","alias":"leukemia-chemotherapy"}],"diagnostics":[{"name":"MRI of one area","alias":"mri-one-department"},{"name":"Ultrasound","alias":"u.s."},{"name":"Biopsy","alias":"biopsy"},{"name":"Tumor Marker Blood Test","alias":"identification-of-tumor-markers"},{"name":"CT (computer tomography)","alias":"ct"},{"name":"Bone marrow biopsy","alias":"bone-marrow-biopsy"},{"name":"Brain MRI","alias":"brain-mri"},{"name":"Comprehensive diagnosis of lymphomas","alias":"comprehensive-diagnosis-of-lymphomas"},{"name":"Online Consultation with Oncologist","alias":"online-consultation-with-oncologist"},{"name":"Online Consultation with Pediatric Hematologist","alias":"online-consultation-with-pediatric-hematologist"}],"illnesses":[{"name":"Lymphoma","alias":"lymphoma"},{"name":"Hodgkin's lymphoma","alias":"hodgkin-s-disease"},{"name":"Aplastic anemia","alias":"aplastic-anemia"},{"name":"Leukemia","alias":"leukemia"},{"name":"Acute lymphoblastic leukemia","alias":"acute-lymphoblastic-leukemia"},{"name":"Non-Hodgkin's lymphoma","alias":"non-hodgkin-s-lymphoma"},{"name":"Follicular lymphoma","alias":"follicular-lymphoma"},{"name":"Burkitt's lymphoma","alias":"burkitt-s-lymphoma"}],"illnessKinds":[{"name":"Hematology Oncology","alias":"hematology"}],"illness_kinds":[{"name":"Hematology Oncology","alias":"hematology"}]},"popularSearches":[{"name":"Chemotherapy","alias":"chemotherapy","type":"operation","id":37},{"name":"Bone marrow transplantation","alias":"bone-marrow-transplantation","type":"operation","id":141},{"name":"Plasmapheresis","alias":"plasmapheresis","type":"operation","id":386},{"name":"CAR T-cell therapy","alias":"car-t-cell-therapy","type":"operation","id":800},{"name":"Biological therapy","alias":"biological-therapy","type":"operation","id":154},{"name":"Ultrasound","alias":"u.s.","type":"diagnostic","id":37},{"name":"MRI of one area","alias":"mri-one-department","type":"diagnostic","id":6},{"name":"Consultation with creation of treatment plan","alias":"consultation-with-creation-of-treatment-plan","type":"diagnostic","id":457},{"name":"CT (computer tomography)","alias":"ct","type":"diagnostic","id":96},{"name":"Complete blood count","alias":"total-blood","type":"diagnostic","id":83},{"name":"Leukemia","alias":"leukemia","type":"illness","id":393},{"name":"Lymphoma","alias":"lymphoma","type":"illness","id":12},{"name":"Aplastic anemia","alias":"aplastic-anemia","type":"illness","id":319},{"name":"Myeloma","alias":"myeloma","type":"illness","id":126},{"name":"Acute lymphoblastic leukemia","alias":"acute-lymphoblastic-leukemia","type":"illness","id":492}],"operationPrices":{"operation_prices":{"800":{"operation":{"name":"CAR T-cell therapy","alias":"car-t-cell-therapy","use_for_listing":true},"country_price":{"US":{"amount":420000,"max_amount":540000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":150000,"max_amount":220000,"currency":"USD","clinic_count":3,"price_kind":"from_range","price_source":"mixed","scope":"country"},"TH":{"amount":150000,"max_amount":220000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"KR":{"amount":220000,"max_amount":300000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"AT":{"amount":280000,"max_amount":365000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"UA":false,"FR":false,"GB":false,"US":false,"IL":true,"TR":true,"MX":false,"DE":false,"CA":false,"AE":false,"TH":false,"PL":false,"KR":false,"CZ":false,"AT":false,"ES":true,"IT":true,"CN":true,"AU":false,"IN":false,"MY":false,"VN":false,"BR":false},"description":"<p>This therapy modifies patient\"s cells to combat cancer, merging immunology and genetics. It\"s precise, powerful, potentially one-off treatment.</p>"},"1699":{"operation":{"name":"CAR-T for DLBCL","alias":"car-t-for-dlbcl","use_for_listing":false},"country_price":{"US":{"amount":420000,"max_amount":530000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":140000,"max_amount":190000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TH":{"amount":5900,"max_amount":250000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"KR":{"amount":280000,"max_amount":360000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"AT":{"amount":290000,"max_amount":380000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"US":false,"TR":false,"TH":true,"KR":false,"AT":false}},"1700":{"operation":{"name":"CAR-T for Multiple Myeloma","alias":"car-t-for-multiple-myeloma","use_for_listing":false},"country_price":{"US":{"amount":420000,"max_amount":540000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":140000,"max_amount":190000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TH":{"amount":5900,"max_amount":280000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"KR":{"amount":280000,"max_amount":400000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"AT":{"amount":330000,"max_amount":430000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"US":false,"TR":false,"TH":true,"KR":false,"AT":false}},"1702":{"operation":{"name":"CAR-T for Pediatric ALL","alias":"car-t-for-pediatric-all","use_for_listing":false},"country_price":{"US":{"amount":475000,"max_amount":650000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TR":{"amount":140000,"max_amount":220000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"TH":{"amount":5900,"max_amount":280000,"currency":"USD","clinic_count":1,"price_kind":"from_range","price_source":"tariff","scope":"country"},"KR":{"amount":280000,"max_amount":410000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"},"AT":{"amount":290000,"max_amount":390000,"currency":"USD","clinic_count":0,"price_kind":"estimate","price_source":"parsed","scope":"country"}},"available_clinics":{"US":false,"TR":false,"TH":true,"KR":false,"AT":false}}}},"operationIndicators":{"details":{"anesthesia":"general","days_in_clinic":7,"days_in_country":14,"rehabilitation_days":30,"satisfied_percent":78,"treatment_duration_hours":4},"illness_kind_details":{"requests_processed":6882}},"direction":{"id":20,"name":"Hematology Oncology","alias":"hematology"},"illness_kind":{"id":20,"name":{"en":"Hematology Oncology"}},"parsed_details":{"procedure_type":"therapy","fields":{"anesthesia":["none"],"back_to_work_days":{"min":60,"max":90,"unit":"days","qualifier":"Desk work usually resumes at 2–3 months, once CRS/ICANS risk and cytopenias settle. Later if fatigue, neurotoxicity or infections persist."},"complication_rate_pct":{"min":50,"max":95,"unit":"percent","qualifier":"Any-grade cytokine release syndrome or neurotoxicity within about 8 weeks; severe grade 3+ events roughly 10-25%."},"contraindications":["Active uncontrolled infection, including uncontrolled hepatitis B/C or HIV","Significant cardiac, pulmonary, renal or hepatic dysfunction","Active CNS or autoimmune neurological disease (relative, product-dependent)","Poor performance status or rapid progression during manufacturing (relative)","Severe hypersensitivity to DMSO or product excipients","Pregnancy or breastfeeding","Active uncontrolled graft-versus-host disease (relative, prior transplant)"],"days_in_clinic":{"min":10,"max":21,"unit":"nights","qualifier":"Inpatient stay with daily CRS/ICANS monitoring, about 2 weeks; longer if ICU needed."},"diagnostic_duration_minutes":null,"diagnostic_preparation":null,"diagnostic_referral_needed":null,"diagnostic_result_time_hours":null,"exercise_resume_weeks":{"min":8,"max":12,"unit":"weeks","qualifier":"Strenuous exercise waits about 2–3 months, until counts recover and early neurotoxicity and infection risk passes. Light walking earlier."},"final_result_months":{"min":1,"max":3,"unit":"months","qualifier":"Response is assessed at about 1 month and 3 months after infusion; remission durability needs longer follow-up."},"fly_home_after_days":{"min":28,"max":42,"unit":"days","qualifier":"Stay near the centre at least 4 weeks, past peak CRS/ICANS risk. Fly if no toxicity, counts acceptable."},"follow_up_visits":[{"purpose":"assessment","requirement":"routine","after":{"min":7,"max":14,"unit":"days","qualifier":"Frequent early monitoring for cytokine release syndrome and neurotoxicity if discharged"}},{"purpose":"result_review","requirement":"routine","after":{"min":28,"max":35,"unit":"days","qualifier":"First response assessment, about day 28-35 after infusion"}},{"purpose":"result_review","requirement":"routine","after":{"min":85,"max":100,"unit":"days","qualifier":"Response reassessment about day 85-100 (around 3 months) after infusion"}}],"indications":["Relapsed or refractory large B-cell lymphoma","Relapsed or refractory B-cell acute lymphoblastic leukemia","Relapsed or refractory follicular and mantle cell lymphoma","Relapsed or refractory multiple myeloma (BCMA-directed)","Relapsed or refractory chronic lymphocytic leukemia"],"main_risks":["Cytokine release syndrome","Immune effector cell-associated neurotoxicity syndrome","Prolonged cytopenias","Infections and hypogammaglobulinemia","B-cell aplasia","Hemophagocytic lymphohistiocytic-like syndrome","Secondary T-cell malignancies (rare)","Tumor lysis syndrome","Infusion-related hypersensitivity reactions"],"pain":"The infusion itself is generally painless; fever, headache, body aches and malaise may occur with cytokine release, and leukapheresis involves line placement with mild discomfort.","preparation":["Specialist eligibility assessment and disease staging","Infection screening and organ function evaluation","Leukapheresis to collect the patient's T cells","Possible bridging therapy while the cells are manufactured (weeks)","Lymphodepleting chemotherapy a few days before infusion","Central venous access as needed","Arrange nearby accommodation and a caregiver after infusion","Confirm target antigen (e.g., CD19, BCMA) and prior-therapy eligibility","Pre-infusion premedication (paracetamol and antihistamine)","Access to tocilizumab and ICU-level support before infusion"],"recovery_timeline":[{"phase":"Infusion and first 1-2 weeks","description":"Single IV infusion followed by close monitoring for cytokine release syndrome and neurotoxicity, usually peaking in the first 1-2 weeks.","restrictions":["Stay near the treatment center"]},{"phase":"Weeks 2-4","description":"Discharge when stable, frequent visits, blood count and infection monitoring, first response assessment around day 28.","restrictions":["Stay near the treatment center until about day 28","No driving for at least 8 weeks","Avoid crowds and infection exposure"]},{"phase":"Months 2-12","description":"Gradual recovery of blood counts and energy, immune function monitoring, immunoglobulin replacement if needed, response reassessment.","restrictions":["Delay live vaccines per specialist advice"]}],"rehabilitation_days":{"min":60,"max":90,"unit":"days","qualifier":"Functional recovery after the 4-week monitoring period; slower with persistent fatigue, cytopenias, neurotoxicity or infections."},"result_longevity":"In large B-cell lymphoma, about 40% remain progression-free at 1 year; some stay in long-term remission. In B-ALL, about 36% relapse; CAR T cells can persist up to about 5 years.","revision_rate_pct":null,"scars":"There is no surgical incision, only small puncture marks from the leukapheresis or central venous line sites.","sessions_or_stages":{"sessions":{"min":1,"max":1,"unit":"visits","qualifier":"One CAR T-cell infusion; leukapheresis and lymphodepletion are preceding stages."},"stages":[{"code":"leukapheresis","label":"Leukapheresis to collect T cells","after":{"min":0,"max":0,"unit":"days","qualifier":"Starting point of the treatment pathway"}},{"code":"lymphodepletion","label":"Lymphodepleting chemotherapy","after":{"min":23,"max":58,"unit":"days","qualifier":"About 3-8 weeks after leukapheresis; 2-5 days before infusion"}},{"code":"car_t_infusion","label":"CAR T-cell infusion","after":{"min":28,"max":63,"unit":"days","qualifier":"Depends on manufacturing and product release time"}}],"qualifier":"Single-infusion therapy; timelines vary by product and center."},"success":{"metric":"Complete response rate in relapsed/refractory large B-cell lymphoma (3rd-line or later)","value":51,"unit":"percent","horizon":"Best response, typically assessed at 1-3 months after infusion","evidence_status":"limited","population":"Adults with relapsed/refractory LBCL after two or more prior lines"},"techniques":[{"name":"Autologous CD19-directed CAR T-cell therapy","suits_whom":"Relapsed/refractory B-cell lymphomas and B-ALL","recovery":"Inpatient monitoring about 10-21 days, then nearby follow-up to day 28."},{"name":"Autologous BCMA-directed CAR T-cell therapy","suits_whom":"Relapsed/refractory multiple myeloma after multiple prior lines","recovery":"Similar monitoring; prolonged cytopenias are common."}],"treatment_conditions":["inpatient"],"treatment_duration_hours":{"min":0.5,"max":1,"unit":"hours","qualifier":"Duration of the single CAR T-cell infusion itself; leukapheresis (about 3-6 hours) and lymphodepletion are separate."},"initial_assessment_documents":["Pathology report with CD19 or BCMA status","Summary of prior treatment lines and responses","Recent PET-CT or MRI report","Bone marrow biopsy report","Recent CBC, kidney and liver function tests","Echocardiogram report (if available)"],"travel_trips":{"min":1,"max":2,"one_trip_possible":true,"qualifier":"Cell collection, then 3-9 weeks manufacturing, usually at home; return for infusion and 4+ weeks nearby. One trip means staying."},"clinic_checks":{"status":"ok","items":[{"id":"C1","text":"Ask the clinic for examples of the practitioners' experience with the exact procedure you are planning","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Ask for examples of the practitioners’ experience with the surgery you are intending to have.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"C2","text":"Ask whether a doctor is always present in the clinic and whether a high dependency or intensive care unit exists","scope":"treatment_abroad","source":{"url":"https://www.bapras.org.uk/public/patient-information/cosmetic-surgery/cosmetic-surgery-abroad","host":"bapras.org.uk","quote":"Is there always a doctor in the clinic and is there a high dependency or intensive care unit?","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C3","text":"Confirm the surgeon is trained and experienced in the exact procedure you are considering, not just in surgery generally","scope":"treatment_abroad","source":{"url":"https://www.isaps.org/discover/patients-home/considering-your-procedure-abroad/finding-a-surgeon-abroad/","host":"isaps.org","quote":"Verify that the surgeon is trained and experienced in performing the procedure you are considering.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C4","text":"Check that the surgeon who consults with you is the same person who will carry out the procedure","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Check that the surgeon you consult with, will be the same person carrying out the procedure.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"C5","text":"Decide before you travel where check-ups after the operation will take place, because follow-up abroad may be missing or weaker","scope":"treatment_abroad","source":{"url":"https://www.nhs.uk/conditions/cosmetic-procedures/cosmetic-surgery-abroad/","host":"nhs.uk","quote":"You need to think about where check-ups will take place.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"red_flags":{"status":"ok","items":[{"id":"F1","text":"Pressure to decide quickly, or cheap time-limited offers, is a warning sign of a clinic offer","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"F2","text":"An advert or information that guarantees complete success should raise concerns","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Any advert or information that guarantees complete success should raise concerns.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}},{"id":"F3","text":"Forceful persuasion or cheap, time-limited offers pushing you into a quick decision","scope":"treatment_abroad","source":{"url":"https://travelaware.campaign.gov.uk/surgery-abroad-cut-out-the-risk/","host":"travelaware.campaign.gov.uk","quote":"Don’t be pressured into quick decisions either through forceful persuasion or cheap, time limited offers.","tier":"tier1_medical","fetched_at":"2026-11-11","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"warning_signs":{"status":"ok","items":[{"id":"W1","text":"Confusion or difficulty communicating","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Patients also may experience neurologic symptoms such as confusion, tremors, or difficulty communicating.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W2","text":"Excessive sleepiness","urgency":"contact_clinic","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/research/car-t-cells","host":"cancer.gov","quote":"Some of the hallmark signs of ICANS include confusion, excessive sleepiness, and impaired speech.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W3","text":"Trouble breathing","urgency":"emergency","general":false,"source":{"url":"https://www.cancer.gov/about-cancer/treatment/side-effects/flu-symptoms","host":"cancer.gov","quote":"Immunotherapy treatments such as CAR T-cell therapy and some monoclonal antibodies may cause cytokine release syndrome (CRS), a condition that can lead to severe flu-like symptoms as well as a rash, rapid heartbeat, low blood pressure, and trouble breathing.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"W4","text":"Fever","urgency":"contact_clinic","general":true,"source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2019/cancer-immunotherapy-investigating-side-effects","host":"cancer.gov","quote":"Many patients who receive CAR T-cell therapy develop a condition known as cytokine release syndrome, which can cause a fever, fast heart rate, low blood pressure, and rash, among other symptoms.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"take_home":{"status":"ok","items":[{"id":"T1","text":"Shows emergency staff and other doctors the patient is a CAR T recipient","document":"car t wallet card","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/car-cell-therapy-guide-adult-patients-caregivers","host":"mskcc.org","quote":"Carry your wallet card with you at all times.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T2","text":"Home doctor needs the plan the treating team set for leaving hospital","document":"written discharge instructions","source":{"url":"https://www.mskcc.org/cancer-care/patient-education/car-cell-therapy-guide-adult-patients-caregivers","host":"mskcc.org","quote":"Your CAR T team will give you discharge instructions before you leave the hospital.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},{"id":"T3","text":"Home doctor needs the exact medicines to continue treatment safely","document":"discharge medicines list","source":{"url":"https://www.cuh.nhs.uk/patient-information/discharge-advice-from-ward-c10c9-following-car-t-cell-therapy/","host":"cuh.nhs.uk","quote":"You will be given a copy of all the medications that you should take after being discharged.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"alternatives":{"status":"ok","items":[{"id":"A1","text":"You are older and not eligible for CAR T-cell therapy","name":"Bispecific antibody therapy","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2022/tecvayli-multiple-myeloma","host":"cancer.gov","quote":"with bispecific antibodies you'll be able to treat older patients who are not eligible for CAR T-cell therapies","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200},"operation_id":null}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"technique_details":{"status":"ok","items":[{"id":"autologous-cd19-directed-car","name":"Autologous CD19-directed CAR T-cell therapy","how_it_works":{"text":"Modified T cells recognize an antigen on cancer cells","source":{"url":"https://www.leedsth.nhs.uk/?p=50458","host":"leedsth.nhs.uk","quote":"These new receptors will enable the T-cells to recognise and attach to the antigen on the cancer cell.","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}},{"id":"autologous-bcma-directed-car","name":"Autologous BCMA-directed CAR T-cell therapy","how_it_works":{"text":"Engineered cells are designed to recognize BCMA, a protein on myeloma cells","source":{"url":"https://www.cancer.gov/news-events/cancer-currents-blog/2021/fda-ide-cel-car-t-multiple-myeloma","host":"cancer.gov","quote":"genetic engineering lets the CAR T cells \"see\" BCMA, a protein that's present at high amounts in multiple myeloma cells","tier":"tier1_medical","fetched_at":"2026-11-12","http_status":200}},"recovery_daily":{"status":"missing","reason":"no_official_source"}}],"checked_at":"2026-11-12","next_check_at":"2027-11-12","version":1},"preop_tests":{"status":"ok","items":[{"id":"T1","name":"Complete blood count","aliases":["Complete blood count","CBC","Full blood count"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent CBC, kidney and liver function tests"},{"field":"packages","text":"Complete blood count with cancer markers and a proteinogram"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T2","name":"Biopsy","aliases":["Biopsy","Bone marrow biopsy"],"kind":"other","origin":[{"field":"initial_assessment_documents","text":"Bone marrow biopsy report"},{"field":"packages","text":"Biopsy"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T3","name":"PET-CT scan","aliases":["PET-CT scan","PET-CT","PET/CT"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent PET-CT or MRI report"},{"field":"packages","text":"PET/CT"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T4","name":"MRI scan","aliases":["MRI scan","MRI","Head MRI"],"kind":"imaging","origin":[{"field":"initial_assessment_documents","text":"Recent PET-CT or MRI report"},{"field":"packages","text":"Head MRI"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T5","name":"Echocardiogram","aliases":["Echocardiogram","Echocardiography"],"kind":"heart","origin":[{"field":"initial_assessment_documents","text":"Echocardiogram report (if available)"},{"field":"packages","text":"Echocardiography"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T6","name":"Kidney function test","aliases":["Kidney function test","Kidney function tests"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent CBC, kidney and liver function tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T7","name":"Liver function test","aliases":["Liver function test","Liver function tests"],"kind":"lab","origin":[{"field":"initial_assessment_documents","text":"Recent CBC, kidney and liver function tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T8","name":"Blood tests","aliases":["Blood tests"],"kind":"lab","origin":[{"field":"packages","text":"Blood tests"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T9","name":"Tumor marker test","aliases":["Tumor marker test","Cancer markers"],"kind":"lab","origin":[{"field":"packages","text":"Complete blood count with cancer markers and a proteinogram"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null},{"id":"T10","name":"Serum protein electrophoresis","aliases":["Serum protein electrophoresis","Proteinogram"],"kind":"lab","origin":[{"field":"packages","text":"Complete blood count with cancer markers and a proteinogram"}],"what_it_checks":{"status":"missing","reason":"no_official_source"},"when_needed":{"status":"missing","reason":"no_official_source"},"test_prep":null}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":1},"prep_in_advance":{"status":"ok","items":[{"id":"P1","action":"Ask your team whether chemotherapy or radiation will be given before the T cells are returned to you","why":"The treatment aims to get rid of other immune cells","who_decides":"prescriber","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy","host":"cancer.gov","quote":"During this time, you may have treatment with chemotherapy and, maybe, radiation therapy to get rid of other immune cells.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":1},"visit_and_day":{"status":"ok","has_procedure_day":true,"items":[{"id":"V1","text":"The CAR T-cell product is sent back to the hospital and returned to the patient as a single infusion","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/research/car-t-cells","host":"cancer.gov","quote":"These expanded cells are the final CAR T-cell therapy product, which is sent back to the hospital to be returned to the patient as a single infusion.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}},{"id":"V2","text":"The T cells grown in the lab are given back to the patient through a needle in a vein","anesthesia":"any","source":{"url":"https://www.cancer.gov/about-cancer/treatment/types/immunotherapy/t-cell-transfer-therapy","host":"cancer.gov","quote":"After these treatments, the T cells that were grown in the lab will be given back to you via a needle in your vein.","tier":"tier1_medical","fetched_at":"2026-11-16","http_status":200}}],"checked_at":"2026-11-16","next_check_at":"2027-11-16","version":1},"if_something_changes":{"status":"missing","reason":"no_official_source","checked_at":"2026-11-16","next_check_at":"2027-02-14"},"technique_prices":{"status":"ok","checked_at":"2026-11-17","items":[{"country_iso":"AT","technique_id":"autologous-cd19-directed-car","technique":"Autologous CD19-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":280000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"AT","technique_id":"autologous-bcma-directed-car","technique":"Autologous BCMA-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":340000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"CN","technique_id":"autologous-cd19-directed-car","technique":"Autologous CD19-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":230000,"source":"package","offers":1,"offer_id":"6a61d811cab311a9ce0552c2"},{"country_iso":"CN","technique_id":"autologous-bcma-directed-car","technique":"Autologous BCMA-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":300000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"DE","technique_id":"autologous-cd19-directed-car","technique":"Autologous CD19-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":285000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"DE","technique_id":"autologous-bcma-directed-car","technique":"Autologous BCMA-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":345000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"IL","technique_id":"autologous-cd19-directed-car","technique":"Autologous CD19-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":150000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"IL","technique_id":"autologous-bcma-directed-car","technique":"Autologous BCMA-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":86000,"source":"package","offers":2,"offer_id":"69d6029bedb8b85c1a0bd0e2"},{"country_iso":"IT","technique_id":"autologous-cd19-directed-car","technique":"Autologous CD19-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":400000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"IT","technique_id":"autologous-bcma-directed-car","technique":"Autologous BCMA-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":480000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"KR","technique_id":"autologous-cd19-directed-car","technique":"Autologous CD19-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":220000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"KR","technique_id":"autologous-bcma-directed-car","technique":"Autologous BCMA-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":270000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"ES","technique_id":"autologous-cd19-directed-car","technique":"Autologous CD19-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":380000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"ES","technique_id":"autologous-bcma-directed-car","technique":"Autologous BCMA-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":450000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"TR","technique_id":"autologous-cd19-directed-car","technique":"Autologous CD19-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":150000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"TR","technique_id":"autologous-bcma-directed-car","technique":"Autologous BCMA-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":200000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"GB","technique_id":"autologous-cd19-directed-car","technique":"Autologous CD19-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":330000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"GB","technique_id":"autologous-bcma-directed-car","technique":"Autologous BCMA-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":390000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"US","technique_id":"autologous-cd19-directed-car","technique":"Autologous CD19-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":420000,"source":"estimate","model":"claude-sonnet-5-5"},{"country_iso":"US","technique_id":"autologous-bcma-directed-car","technique":"Autologous BCMA-directed CAR T-cell therapy","currency":"USD","date":"2026-11-17","price_from":500000,"source":"estimate","model":"claude-sonnet-5-5"}]}}},"hrefLanguages":[{"rel":"alternate","hreflang":"ru","language":"ru","href":"https://ru.bookimed.com/clinics/country=republic-of-korea/procedure=car-t-kletocnaa-terapia/"}],"questionsAndAnswers":[{"id":"6a05e9c2c7a0e6929a0a9aa2","question":"Which centers in South Korea are qualified to provide CAR T-cell therapy?","answer":"<p>Qualified centers in South Korea must receive Ministry of Food and Drug Safety approval to administer CAR T-cell therapy. Primary authorized facilities include Samsung Medical Center, Seoul National University Hospital, and Seoul St. Mary Hospital. These institutions manage commercial products like Kymriah for lymphoma and leukemia patients.</p> <ul> <li><strong>Samsung Medical Center:</strong> Established the first dedicated CAR T-Cell Center in South Korea in 2021.</li> <li><strong>Seoul National University:</strong> First hospital authorized to produce CAR T-cells internally for pediatric leukemia cases.</li> <li><strong>Seoul St. Mary:</strong> Features an on-site GMP cell processing center for advanced immune cell research.</li> <li><strong>Regulatory compliance:</strong> Facilities must strictly follow the Advanced Biological Product Safety Act for certification.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Samsung Medical Center serves over 2,000,000 patients annually and maintains a presidential-tier infrastructure. This high volume translates to significant experience in complex oncology. Their early adoption of a dedicated center makes them a leader in managing cytokine release syndrome. This specialized care is vital for patient safety during the aggressive CAR T-cell infusion phase.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the need for official verification. They recommend contacting oncology departments directly to confirm current KFDA approval status for specific therapies. Many suggest budgeting over $300,000 and planning for a 6-week stay.</p>","is_active":true,"created_at":"2026-05-14T15:26:58.983+00:00","category":{"id":"68f5f2ea1567cb687e0a7542","name":"faq_content","title":"faq_content"},"relations":[{"key":"country","value":"republic-of-korea"},{"key":"operation","value":"car-t-cell-therapy"}]},{"id":"6a05ea1b34774719ea0d7522","question":"What CAR T-cell products are commercially approved in the Republic of Korea?","answer":"<p>South Korea's Ministry of Food and Drug Safety has approved four major CAR T-cell therapies: Kymriah (tisagenlecleucel), Yescarta (axicabtagene ciloleucel), Carvykti (ciltacabtagene autoleucel), and Rimqarto (anbalcabtagene autoleucel). These products treat specific lymphomas and multiple myeloma. Administration occurs at specialized centers like Samsung Medical Center.</p> <ul> <li><strong>Kymriah (Novartis):</strong> Approved in 2021 for pediatric ALL and adult DLBCL.</li> <li><strong>Yescarta (Gilead):</strong> Treats relapsed large B-cell lymphoma and primary mediastinal lymphoma.</li> <li><strong>Carvykti (Janssen):</strong> Indicated for adult patients with relapsed or refractory multiple myeloma.</li> <li><strong>Rimqarto (Curocell):</strong> The first homegrown Korean CAR T-cell drug targeting CD19.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While approvals are increasing, manufacturing logistics remain a significant bottleneck. Data shows patients often wait over 6 months for imported products. Top centers like Samsung Medical Center manage these timelines better due to high patient volumes. They serve over 2,000,000 patients annually and have established apheresis protocols.</p> <p><strong>Patient Consensus:</strong> Patients emphasize the need to verify hospital capabilities early. They often report that insurance coverage lags behind regulatory approval, making out-of-pocket costs a major concern.</p>","is_active":true,"created_at":"2026-05-14T15:28:27.023+00:00","category":{"id":"68f5f2ea1567cb687e0a7542","name":"faq_content","title":"faq_content"},"relations":[{"key":"country","value":"republic-of-korea"},{"key":"operation","value":"car-t-cell-therapy"}]},{"id":"6a05ea6b8df1dc3a3e04f5e2","question":"Which hematologic malignancies are reimbursed for CAR T-cell therapy under Korea’s National Health Insurance?","answer":"<p>South Korea National Health Insurance covers CAR T-cell therapy primarily for relapsed or refractory diffuse large B-cell lymphoma and pediatric B-cell acute lymphoblastic leukemia. Coverage usually applies starting from third-line treatment under strict National Health Insurance Service guidelines at accredited medical centers.</p> <ul> <li><strong>Large B-cell lymphoma:</strong> Reimbursed as third-line therapy for adult patients with relapsed or refractory disease.</li> <li><strong>Acute lymphoblastic leukemia:</strong> Covered for pediatric and young adult patients up to 25 years old.</li> <li><strong>Mantle cell lymphoma:</strong> Benefits expanded in 2022 to include this specific hematologic malignancy.</li> <li><strong>Follicular lymphoma:</strong> Approved for clinical use but reimbursement varies significantly by individual case.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> Samsung Medical Center serves over 2,000,000 patients annually and holds KOIHA accreditation for safety. Their high volume suggests they manage the complex National Health Insurance reimbursement and hospital-level approvals efficiently. Patients should verify their specific malignancy against the latest risk-sharing agreements at such high-capacity centers.</p> <p><strong>Patient Consensus:</strong> Patients report that while pediatric leukemia coverage is reliable, many adults with multiple myeloma face private costs. Most advise preparing for a 10% to 20% copay even when insurance approves the treatment.</p>","is_active":true,"created_at":"2026-05-14T15:29:47.000+00:00","category":{"id":"68f5f2ea1567cb687e0a7542","name":"faq_content","title":"faq_content"},"relations":[{"key":"country","value":"republic-of-korea"},{"key":"operation","value":"car-t-cell-therapy"}]},{"id":"6a05eab9630167b87c0ff4b2","question":"What ongoing CAR T-cell clinical trials are recruiting in South Korea?","answer":"<p>South Korea actively recruits for CAR T-cell clinical trials targeting lymphoma, leukemia, and liver cancer. Prominent studies include the ALPHA3 trial for B-cell lymphoma and the EU307 phase 1 trial for hepatocellular carcinoma. Enrollment centers include Samsung Medical Center and Seoul National University Hospital.</p> <ul> <li><strong>Hematologic malignancies:</strong> The ALPHA3 trial evaluates first-line consolidation for large B-cell lymphoma.</li> <li><strong>Leukemia research:</strong> Anbal-cel phase 2 trials investigate treatments for adult acute lymphoblastic leukemia.</li> <li><strong>Solid tumors:</strong> EU307 phase 1 tests anti-GPC3 therapy for advanced liver cancer patients.</li> <li><strong>Autoimmune applications:</strong> Clinics recruit for low-dose CAR-T trials treating refractory Systemic Lupus Erythematosus.</li> </ul> <p><strong>Bookimed Expert Insight:</strong> While many global trials use ClinicalTrials.gov, South Korean centers often prioritize the local CRIS registry. Samsung Medical Center, which serves over 2,000,000 patients annually, frequently operates internal trial pipelines. Checking their specific Cancer Center listings usually reveals more active slots than international databases.</p> <p><strong>Patient Consensus:</strong> Many find that trial information is mainly available in Korean. Direct contact with tier-1 hospital international departments is more effective than searching public online listings.</p>","is_active":true,"created_at":"2026-05-14T15:31:04.882+00:00","category":{"id":"68f5f2ea1567cb687e0a7542","name":"faq_content","title":"faq_content"},"relations":[{"key":"country","value":"republic-of-korea"},{"key":"operation","value":"car-t-cell-therapy"}]},{"id":"6a58baf123028137100d48d2","question":"What are the common side effects of CAR T-cell therapy in Korea?","answer":"<p>Common side effects of CAR T-cell therapy in Korea include Cytokine Release Syndrome (CRS) and neurological toxicity (ICANS). Specialists at centres like Seoul's Samsung Medical Center manage these effects during a mandatory 10-day monitoring period. This monitoring helps protect patient safety and supports long-term recovery.</p>\n<ul>\n<li>Cytokine Release Syndrome: Affects up to 94.8% of patients, typically causing high fevers and chills.</li>\n<li>Neurological toxicity: ICANS impacts 11–50% of patients, causing confusion or speech difficulties during week 2.</li>\n<li>Low blood counts: Cytopenias can persist for 90+ days, increasing the risk of infection.</li>\n<li>Immune suppression: B-cell depletion requires careful monitoring for infections throughout the first year.</li>\n</ul>\n<p><strong>Bookimed Expert Insight:</strong> Data shows Korean oncology centres focus heavily on immediate safety. They require patients to stay within 30 minutes of the hospital for 30 days. Facilities like Samsung Medical Center provide integrated ICU access. They also keep tocilizumab immediately available to neutralise severe immune reactions.</p>\n<p><strong>Patient Consensus:</strong> Patients in Korea find that intensive 10-day hospital monitoring helps catch early symptoms quickly. These symptoms include fever and confusion. Most people report that brain fog and fatigue can last for several months. This happens after the initial hospital stay.</p>\n","is_active":true,"created_at":"2026-07-16T11:05:21.740+00:00","category":{"id":"6a06f09a5f96e66bc80340b2","name":"faq_content_au","title":"faq_content_au"},"relations":[{"key":"country","value":"republic-of-korea"},{"key":"operation","value":"car-t-cell-therapy"}]},{"id":"6a58bb73eb3233cb860bfca2","question":"Which cancers can be treated with CAR T-cell therapy in Korea?","answer":"<p>Republic of Korea clinics provide CAR T-cell therapy for specific relapsed or refractory blood cancers. Approved treatments target B-cell acute lymphoblastic leukaemia, diffuse large B-cell lymphoma, and multiple myeloma. Specialist centres like Samsung Medical Center use MFDS-approved protocols including Kymriah and domestically developed therapies.</p>\n<ul>\n<li>Lymphoma types: Treatments cover diffuse large B-cell lymphoma and follicular lymphoma.</li>\n<li>Leukaemia patients: B-cell precursor acute lymphoblastic leukaemia is treated in patients under 25.</li>\n<li>Multiple Myeloma: Adults with refractory cases can access BCMA-targeted therapies like Carvykti.</li>\n<li>Domestic innovation: Korea recently approved Rimqarto, a homegrown drug specifically for lymphoma.</li>\n<li>Specialist centres: Samsung Medical Center operates Asia's largest cancer centre for complex cases.</li>\n</ul>\n<p><strong>Bookimed Expert Insight:</strong> While most international patients seek Kymriah, Korea’s domestic drug Rimqarto shows significant promise for lymphoma. Samsung Medical Center’s partnership with the Mayo Clinic means these local protocols meet global clinical standards. This dual-track availability provides more options. It benefits patients who do not respond to standard CAR T drugs.</p>\n<p><strong>Patient Consensus:</strong> Patients find the process for blood cancers very established in Seoul. They recommend sticking to MFDS-approved therapies and major medical centres. Trials for solid tumours are interesting but still seen as experimental by most families.</p>\n","is_active":true,"created_at":"2026-07-16T11:07:31.796+00:00","category":{"id":"6a06f09a5f96e66bc80340b2","name":"faq_content_au","title":"faq_content_au"},"relations":[{"key":"country","value":"republic-of-korea"},{"key":"operation","value":"car-t-cell-therapy"}]},{"id":"6a58bbbfeb3233cb860bfca5","question":"What CAR T-cell therapies are currently available in Korea?","answer":"<p>South Korea offers Kymriah, Yescarta, and Carvykti for haematologic malignancies like leukaemia and multiple myeloma. Clinically approved domestic options include Rimqarto, developed by Curocell. Specialists at Samsung Medical Centre administered the first treatments. Costs range from _op_800_price_from_ to _op_800_price_to_.</p>\n<ul>\n<li>Kymriah (tisagenlecleucel): Approved for paediatric acute lymphoblastic leukaemia and adult diffuse large B-cell lymphoma.</li>\n<li>Yescarta (axicabtagene ciloleucel): Treats adults with relapsed or refractory large B-cell lymphoma and mediastinal lymphoma.</li>\n<li>Carvykti (ciltacabtagene autoleucel): Specifically approved for adult patients battling relapsed or refractory multiple myeloma.</li>\n<li>Rimqarto (anbalcabtagene autoleucel): Korea-developed therapy using OVIS technology to improve efficacy in immunosuppressive environments.</li>\n</ul>\n<p><strong>Bookimed Expert Insight:</strong> Samsung Medical Centre serves over 2 million outpatients annually. It also houses one of Asia’s largest cancer centres. Its partnership with the Mayo Clinic means CAR T-cell protocols meet rigorous international standards. Choosing a high-volume centre like this is vital. It helps manage the intensive care required after infusion.</p>\n<p><strong>Patient Consensus:</strong> Patients find that accessing Kymriah in Korea is more affordable than in Australia. This is due to local insurance coverage. Many travellers look for clinical trials in Seoul. They seek newer therapies that are not yet available commercially.</p>\n","is_active":true,"created_at":"2026-07-16T11:08:47.940+00:00","category":{"id":"6a06f09a5f96e66bc80340b2","name":"faq_content_au","title":"faq_content_au"},"relations":[{"key":"country","value":"republic-of-korea"},{"key":"operation","value":"car-t-cell-therapy"}]},{"id":"6a58bc1e08acb868f90a6644","question":"Are there clinical trials available for CAR T-cell therapy in Korea?","answer":"<p>South Korea offers numerous clinical trials for CAR T-cell therapy. These focus on blood cancers and solid tumours. Institutions such as Samsung Medical Center and Seoul National University Hospital lead these studies. Recent local approvals like Anbal-cel provide additional options alongside global therapies like Kymriah.</p><ul><li>Homegrown trials: Curocell and AbClon conduct Phase 2 trials for diffuse large B-cell lymphoma.</li><li>Solid tumour research: Trials explore CAR-T applications for liver, ovarian, and bile duct cancers.</li><li>Specialised centres: Samsung Medical Center operates a dedicated CAR T-Cell Therapy Centre for trials.</li><li>Autoimmune expansion: New clinical studies at local hospitals now target refractory lupus patients.</li></ul><p><strong>Bookimed Expert Insight:</strong> Samsung Medical Center serves over 2 million outpatients annually. It also maintains a direct partnership with the Mayo Clinic. This connection often gives patients faster access to international trial protocols. It also offers collaborative expertise for complex cases. It is a major differentiator for those seeking high-volume clinical experience in Seoul.</p><p><strong>Patient Consensus:</strong> Korea's Regenerative Medicine Law allows access to cell therapies for severe conditions outside traditional trials. Patients suggest that during consultations, clinics should distinguish CAR T-cell therapy from standard stem cell treatments.</p>\n","is_active":true,"created_at":"2026-07-16T11:10:22.195+00:00","category":{"id":"6a06f09a5f96e66bc80340b2","name":"faq_content_au","title":"faq_content_au"},"relations":[{"key":"country","value":"republic-of-korea"},{"key":"operation","value":"car-t-cell-therapy"}]},{"id":"6a58bcb7869f292acc0b76e2","question":"Is CAR T-cell therapy covered by National Health Insurance in Korea?","answer":"<p>South Korea National Health Insurance (NHI) covers CAR T-cell therapy for eligible residents with specific blood cancers. Since April 2022, Kymriah is reimbursed for third-line treatment of diffuse large B-cell lymphoma. It also covers paediatric acute lymphoblastic leukaemia in the third line. Coverage significantly reduces costs for those enrolled in the national scheme.</p>\n<ul>\n<li>Covered conditions: Applies to relapsed or refractory diffuse large B-cell lymphoma and B-cell leukaemia.</li>\n<li>Specific product: Reimbursement currently focuses on Kymriah for patients up to 25 years old.</li>\n<li>Clinical guidelines: Coverage typically starts from the third line of treatment for eligible patients.</li>\n<li>Outpatient costs: Residents with serious illnesses often pay only 5% of total treatment bills.</li>\n</ul>\n<p><strong>Bookimed Expert Insight:</strong> While NHI offers massive savings, these benefits only apply to residents. International patients usually pay full price, which ranges from _op_800_price_from_ to _op_800_price_to_. Samsung Medical Center, Asia's largest cancer centre, manages these complex cases regularly.</p>\n<p><strong>Patient Consensus:</strong> Korea provides high coverage for cancer through NHI. Foreigners without residency should prepare for costs 20 times higher than local residents. Major hospitals in Seoul offer the most reliable guidance on insurance eligibility.</p>\n","is_active":true,"created_at":"2026-07-16T11:12:55.586+00:00","category":{"id":"6a06f09a5f96e66bc80340b2","name":"faq_content_au","title":"faq_content_au"},"relations":[{"key":"country","value":"republic-of-korea"},{"key":"operation","value":"car-t-cell-therapy"}]},{"id":"6a58bd039e40fe7ade02c4f2","question":"What are the main challenges of CAR T-cell therapy in Korea?","answer":"<p>CAR T-cell therapy in Korea faces several challenges. These include high costs (from _op_800_price_from_ to _op_800_price_to_). Other challenges are limited access outside Seoul and complex logistics for cell manufacturing. Patients must also manage severe clinical toxicities like Cytokine Release Syndrome (CRS). They need specialised intensive care facilities for this.</p>\n\n<ul>\n<li>Financial barriers: Treatment costs range from _op_800_price_from_ to _op_800_price_to_ for international patients.</li>\n<li>Geographic concentration: Most certified centres, including Samsung Medical Centre, are located in Seoul.</li>\n<li>Logistical hurdles: Patient cells often require transport to overseas manufacturing sites before infusion.</li>\n<li>Clinical toxicity: Severe side effects like neurotoxicity require 24-hour monitoring by specialist teams.</li>\n<li>Infrastructure needs: Facilities must have dedicated units for white blood cell collection (leukapheresis).</li>\n</ul>\n\n<p><strong>Bookimed Expert Insight:</strong> While costs are high, Bookimed data shows Samsung Medical Centre manages over 2 million outpatients annually. They partner with the Mayo Clinic and use integrated digital imaging systems. Together, these help manage complex CAR T-cell cases. Patients should confirm specific product availability as Korean approval varies by cancer type.</p>\n\n<p><strong>Patient Consensus:</strong> Success rates for severe relapsed cases can sit around 40% in Korea. Recovery requires strict isolation and 4+ months of precautions like eating only cooked food. Patients frequently have low blood counts and weakened immunity. This can last for months after treatment.</p>\n","is_active":true,"created_at":"2026-07-16T11:14:11.118+00:00","category":{"id":"6a06f09a5f96e66bc80340b2","name":"faq_content_au","title":"faq_content_au"},"relations":[{"key":"country","value":"republic-of-korea"},{"key":"operation","value":"car-t-cell-therapy"}]},{"id":"5ed9f08a88e8aa5daa4ae4c3","question":"Do I need a visa to South Korea?","answer":"<p><span style=\"background-color:rgb(255,255,255);color:rgb(51,51,51);\">Today, South Korea has visa-free agreements with </span><a href=\"https://en.wikipedia.org/wiki/Visa_policy_of_South_Korea#Visa-free_entry\"><u>112 states</u></a><span style=\"background-color:rgb(255,255,255);color:rgb(51,51,51);\">. None visa is required for stays under 90 days or less. To stay longer in this country, you need a visa. What states need a visa for treatment in South Korea and what countries can cross the border free and easy read </span><a href=\"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/SouthKorea.html\"><u>here</u></a><span style=\"background-color:rgb(255,255,255);color:rgb(51,51,51);\">.</span></p>","is_active":true,"created_at":"2020-06-05T07:13:14.000+00:00","category":{"id":"5e3aa27eb517bb3ffb486c42","name":"Texts","title":"Texts"},"relations":[{"key":"country","value":"republic-of-korea"}]},{"id":"5ed9ee4e31e02c46c85d468f","question":"What is the level of medicine in South Korea?","answer":"<p style=\"margin-left:0px;\">Healthcare is the key development sector of the Korean government. The Korean authorities are convinced that care for the citizens' health should be an absolute priority of state policy and spend about <a href=\"https://www.imtj.com/country/KR/#horizontalTab5\"><u>1 billion a year</u></a> for medical tourists attraction.</p><p style=\"margin-left:0px;\">According to <a href=\"https://en.wikipedia.org/wiki/Healthcare_in_South_Korea\"><u>Mark Britnell</u></a>, hospitals dominate the health system. 94% of hospitals are privately owned.</p>","is_active":true,"created_at":"2020-06-05T07:03:42.000+00:00","category":{"id":"5e3aa27eb517bb3ffb486c42","name":"Texts","title":"Texts"},"relations":[{"key":"country","value":"republic-of-korea"}]},{"id":"5ed9f23388e8aa5daa4ae4c6","question":"What are the most popular plastic surgery procedures?","answer":"<p>According to <a href=\"https://www.plasticsurgery.org/documents/News/Statistics/2018/plastic-surgery-statistics-full-report-2018.pdf\">ASPS</a> statistics, 17.7 mln cosmetic surgeries and 5.8 mln reconstructive procedures have been performed in 2018. Among cosmetic procedures the most popular are:</p><ul><li>breast augmentation</li><li>liposuction</li><li>rhinoplasty (nose job)</li><li>eyelid surgery</li><li>tummy tuck.</li></ul><p>Tumor removal, laceration repair, maxillofacial surgery, scar revision, hand surgery are the most common operations in the context of reconstructive surgery.</p>","is_active":true,"created_at":"2020-06-05T07:20:19.000+00:00","category":{"id":"5e3aa27eb517bb3ffb486c42","name":"Texts","title":"Texts"},"relations":[{"key":"country","value":"republic-of-korea"}]},{"id":"5ed9f0ae88e8aa5daa4ae4c4","question":"What documents are required to apply for a visa to South Korea for treatment?","answer":"<p style=\"margin-left:0px;\">Visas for travel to South Korea require a <a href=\"https://travel.state.gov/content/travel/en/international-travel/International-Travel-Country-Information-Pages/SouthKorea.html\"><u>number of documents</u></a>. The necessary papers can be submitted 90 days before the planned departure. Lists of documents includes:</p><ul><li>ID card</li><li>confirmation of online registration and filling out the questionnaire</li><li>certificate of income and availability of funds</li><li>insurance policy for a stay in South Korea (original and copy)</li><li>2 photos (5x6)</li><li>visa receipt</li><li>booking of flight and hotel</li><li>medical opinion about the need for treatment.</li></ul>","is_active":true,"created_at":"2020-06-05T07:13:50.000+00:00","category":{"id":"5e3aa27eb517bb3ffb486c42","name":"Texts","title":"Texts"},"relations":[{"key":"country","value":"republic-of-korea"}]},{"id":"5ed9ee1831e02c46c85d468e","question":"What should you know about South Korea before the trip?","answer":"<figure class=\"table\"><table><tbody><tr><td><p style=\"margin-left:0px;\">Currency</p></td><td><p style=\"margin-left:0px;\">South Korean Won (you also can pay for services in dollars)</p></td></tr><tr><td><p style=\"margin-left:0px;\">Best period for the trip</p></td><td><p style=\"margin-left:0px;\">April, May &amp; June or September, October &amp; November.</p></td></tr><tr><td><p style=\"margin-left:0px;\">Language</p></td><td><p style=\"margin-left:0px;\">Korean (most of medical staff speaks English fluently)</p></td></tr><tr><td><p style=\"margin-left:0px;\">Visa</p></td><td><p style=\"margin-left:0px;\">none required for stays under 90 days or less</p></td></tr><tr><td><p style=\"margin-left:0px;\">Time difference with Europe</p></td><td><p style=\"margin-left:0px;\">9 hours</p></td></tr><tr><td><p style=\"margin-left:0px;\">Time difference with the USA</p></td><td><p style=\"margin-left:0px;\">9 hours</p></td></tr><tr><td><p style=\"margin-left:0px;\">Capital</p></td><td><p style=\"margin-left:0px;\">Seoul</p></td></tr><tr><td><p style=\"margin-left:0px;\">Medical tourism center</p></td><td><p style=\"margin-left:0px;\">Seoul</p></td></tr><tr><td><p style=\"margin-left:0px;\">Popular resorts</p></td><td><p style=\"margin-left:0px;\">Gangwon-do, Gyeongju, Boseong, Jeju</p></td></tr></tbody></table></figure>","is_active":true,"created_at":"2020-06-05T07:02:48.000+00:00","category":{"id":"5e3aa27eb517bb3ffb486c42","name":"Texts","title":"Texts"},"relations":[{"key":"country","value":"republic-of-korea"}]},{"id":"5ed9f06a389d4131a9501f93","question":"What hotel services are provided here?","answer":"<p><span style=\"background-color:rgb(255,255,255);color:rgb(51,51,51);\">In South Korea, </span><a href=\"https://www.tripadvisor.com/Hotels-g294197-zff12-Seoul-Hotels.html\"><u>hotels of different</u></a><span style=\"background-color:rgb(255,255,255);color:rgb(51,51,51);\"> price ranges and service levels are presented. Most tourists choose 4 and 5 star hotels with all-inclusive meals. Such hotels have everything for a comfortable stay: varied food, a large well-groomed territory, animation for children and adults. Some hotels have their own water park, which guests can use for free. Budget travelers can afford to book an economical 3-star hotel with half board or no meals at all.</span></p>","is_active":true,"created_at":"2020-06-05T07:12:42.000+00:00","category":{"id":"5e3aa27eb517bb3ffb486c42","name":"Texts","title":"Texts"},"relations":[{"key":"country","value":"republic-of-korea"}]}],"seoTests":{"thin_content":false,"no_txt_after_3_clinics":false},"offerFilters":{"offer_count":0,"country_filter":[{"id":1,"name":"Israel","alias":"israel","iso_code":"IL"},{"id":203,"name":"China","alias":"china","iso_code":"CN"},{"id":46,"name":"Turkey","alias":"turkey","iso_code":"TR"}],"price_filter":{"from":0,"to":0,"avg":0}},"leadsCount":{"leads_count":2},"manualSeo":[],"updatedAt":"2026-11-16T04:50:12.000Z","activeCountries":["KR","TR","AT","TH"],"hasVideoReviewsByContext":false,"hasCriticalApiFallback":false}